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Abstract
Background: Low back pain is a highly prevalent condition with a significant global burden. Management of lifestyle
factors such as overweight and obesity may improve low back pain patient outcomes. Currently there are no randomised
controlled trials that have been conducted to assess the effectiveness of lifestyle behavioural interventions in managing
low back pain. The aim of this trial is to determine if a telephone-based lifestyle behavioural intervention is effective in
reducing pain intensity in overweight or obese patients with low back pain, compared to usual care.
Methods/Design: A randomised controlled trial will be conducted with patients waiting for an outpatient consultation
with an orthopaedic surgeon at a public tertiary referral hospital within New South Wales, Australia for chronic low back
pain. Patients will be randomly allocated in a 1:1 ratio to receive a lifestyle behavioural intervention (intervention group)
or continue with usual care (control group). After baseline data collection, patients in the intervention group will receive
a clinical consultation followed by a 6-month telephone-based lifestyle behavioural intervention (10 individually tailored
sessions over a 6-month period) and patients in the control group will continue with usual care. Participants will
be followed for 26 weeks and asked to undertake three self-reported questionnaires at baseline (pre-randomisation),
week 6 and 26 post randomisation to collect primary and secondary outcome data. The study requires a sample of 80
participants per group to detect a 1.5 point difference in pain intensity (primary outcome) 26 weeks post randomisation.
The primary outcome, pain intensity, will be measured using a 0–10 numerical rating scale.
Discussion: The study will provide robust evidence regarding the effectiveness of a lifestyle behavioural intervention in
reducing pain intensity in overweight or obese patients with low back pain and inform management of these patients.
Trial registration number: Australian New Zealand Clinical Trials Registry, ACTRN12615000478516, Registered
14/05/2015.
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Background
Low back pain is a common condition and poses signifi-
cant burden to individuals and society. Globally, the me-
dian point prevalence of low back pain has been reported
to be 15 % [1] and the global lifetime prevalence as high
as 84 % [2]. The latest Global Burden of Disease Study
(2013) reported over 651 million cases of low back pain in
2013, which is the leading cause of disability measured [3].
As a consequence, low back pain represents a consider-
able economic burden. Direct costs of care are reported to
be more than $AU4.7 billion in Australia (2012 values),
more than £1.6 billion in the United Kingdom (1998
values) and as much as $US90 billion in the United States
(1998 values) [4, 5].
While the aetiology of low back pain remains unclear, it
is now widely accepted that effective treatment for low
back pain requires consideration of the psychological and
behavioural factors. Several lifestyle behavioural factors
are reported to be associated with an increased prevalence
and persistence of low back pain including weight, sleep
disturbance, psychological distress, and beliefs. Among
the most compelling evidence is the association between
overweight and obesity and low back pain [6, 7]. One
meta-analysis which included 33 cross-sectional and co-
hort studies, found significant associations between over-
weight or obesity and a range of low back pain outcomes.
Data from the cohort studies showed that overweight or
obesity is associated with an increased 12-month preva-
lence of low back pain (n = 6828; OR 1.21, 95 % CI: 1.07,
1.37), increased risk of chronic low back pain (defined as
longer than 3 months in duration; OR 1.43, 95 % CI: 1.28,
1.60), and higher rates of health care seeking for low back
pain (OR 1.56, 95 % CI: 1.46, 1.67) [7]. Similar associations
have been reported for body mass index (BMI) [8]. While
the association between physical activity and diet and low
back pain is less consistent, these are key drivers of weight
gain [9]. Certainly, patients with low back pain who are
overweight or obese, are likely to have more complex
health needs requiring focus on a holistic lifestyle and be-
havioural approach to management.
Given these widely reported associations between lifestyle
behavioural factors and low back pain, it is suggested that
targeting these as part of low back pain management could
improve patient outcomes [7, 10, 11]. While international
guidelines for weight management recommend behavioural
modification interventions as the preferred approach to
managing weight loss and healthy lifestyle there is limited
evidence to guide such care in patients with low back pain
[9]. Several systematic reviews have found no randomised
controlled trials (RCT) reporting the effectiveness of life-
style behavioural interventions in managing persistent low
back pain [10, 12]. To the author’s knowledge only one pre-
post study of a 52 week medically supervised weight loss
program for obese patients with low back pain has been
conducted. The study found a statistically significant weight
loss of 15.3 kg (95 % CI: 7.8, 22.8) was associated with a sig-
nificant improvement in pain related disability (Oswestry
Disability Index (ODI) baseline 31.9 ± 17.7, follow-up 27.1
± 20.9, p = 0.009) [13]. While promising, there is a need to
test the effectiveness of lifestyle behavioural interventions
on low back pain outcomes in robust RCTs.
Given the large numbers of patients who suffer from low
back pain and are overweight or obese [6, 7], an important
consideration is to provide cost effective interventions that
are accessible to a large proportion of overweight patients
at relatively lower cost to patients. Telephone-based inter-
ventions as a treatment delivery modality has potential to
provide greater access to treatment for patients, and over-
comes barriers to accessing continued care, including time
and travel requirements to attend face-to-face appoint-
ments, and flexible scheduling of contact [14]. Importantly,
telephone-based interventions that include behavioural
modification and adjunct psychological strategies are
consistently shown to be as effective as face-to-face inter-
ventions in achieving weight loss [15, 16]. For the key de-
terminants of weight loss; physical activity and diet
modification, telephone-based interventions have also been
shown to be more cost-effective compared to clinical face-
to-face practices [14].
The primary objective of the study is to determine if a
telephone-based lifestyle behavioural intervention is ef-
fective in reducing pain intensity in overweight or obese
patients with low back pain, compared to usual care.
Secondary objectives are to investigate if the interven-
tion improves key secondary outcomes: disability and
function, anthropometry (weight, BMI, waist circumfer-
ence), quality of life, diet, physical activity and health
care utilisation, compared to usual care.
Methods
Study design and setting
The study will employ a parallel group randomised
controlled design (Fig. 1), as part of a cohort multiple
RCT [17]. This pragmatic design utilises participants
from our existing cohort of routine service; patients are
randomised to be offered a new clinical intervention
(intervention group) or to remain part of the cohort
(control group). The control group is not aware of the
intervention trial and thus act as a real world usual care
comparison. This protocol adheres to the requirements
of the Standard Protocol Items: Recommendations for
Intervention Trials (SPIRIT) guidelines and is prospect-
ively registered with the Australian New Zealand Clin-
ical Trials Registry (ACTRN12615000478516). The trial
will be undertaken in the Hunter New England Local
Health District, New South Wales (NSW), Australia.
Ethical approval has been obtained from the Hunter
New England Human Research Ethics Committee
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(approval No. 13/12/11/5.18) and the University of
Newcastle Human Research Ethics Committee (ap-
proval No. H-2015-0043).
Population and recruitment
One hundred and sixty patients waiting for an outpatient
orthopaedic consultation at a public tertiary referral hos-
pital within NSW for non-specific low back pain will be re-
cruited. All patients over 18 years of age waiting for an
outpatient consultation for low back pain will be sent an
information letter to invite participation in a telephone sur-
vey as part of the ongoing cohort study. Patients will be
asked to contact the researchers if they do not wish to par-
ticipate or can refuse upon receipt of the telephone call.
Patients consenting to the telephone survey will then be
screened for eligibility for the RCT by a trained interviewer,
invited to participate if eligible for the study and asked to
complete the baseline survey at the time of the call.
To be eligible participants must meet the following
criteria:
 Chronic low back pain defined as: pain in the lower
back (i.e. between the 12th rib and buttock crease)
with/without leg pain and a duration of longer than
3 months since the onset of pain [18];
 Aged 18 years or older;
 Classified as overweight or obese with a BMI of
≥27 kg/m2 and <40 kg/m2 – based on self-reported
weight and height;
 Have access to and can use a telephone;
 Low back pain severe enough to cause at least
average low back pain intensity ≥3 of 10 on a 0–10
numerical rating scale (NRS) in the last week or
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Fig. 1 Progress of participants through the study
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moderate level of interference in activities of daily
living (adaptation of item 8 on SF36).
Patients will be excluded if they meet the following
criteria:
 Known or suspected serious pathology as the
underlying cause of back pain (e.g. fracture, cancer,
infection, inflammatory arthritis, cauda equine
syndrome);
 A previous history of obesity surgery;
 Currently participating in any prescribed, medically
supervised or commercial weight loss program;
 Back surgery in the last 6 months or booked in for
surgery in the next 6 months;
 Unable to comply with the study protocol that
requires them to, adapt meals or exercise, due to
non-independent living arrangements;
 Any medical or physical impairment, apart from
back pain, precluding safe participation in exercise
such as uncontrolled hypertension, or morbid
obesity (BMI ≥40);
 Cannot speak and read English sufficiently to
complete the study procedures.
Randomisation and blinding
A randomisation schedule will be created a priori by an
independent investigator using SAS 9.3 through the SUR-
VEYSELECT procedure. Consenting patients who are eli-
gible for the trial will be allocated, in a 1:1 allocation ratio,
to either receive the lifestyle behavioural intervention at
that time (intervention group) or remain as part of the co-
hort and be told they will be offered clinical services in
6 months (control group). To randomise patients, a
trained interviewer will open a sealed opaque envelope
containing group allocation. A staff member not involved
in the study will prepare the envelopes. Patient progress
through the study is outlined in Fig. 1.
All outcome assessors will be blind to group allocation.
Treatments
Intervention group
Patients randomised to the intervention group will be pro-
vided brief advice and education about the benefits of
weight loss and physical activity for their conditions by
trained telephone interviewers. Participants will then be
invited to attend a one hour consultation with the study
physiotherapist at Hunter New England Population Health,
NSW, Australia and referred to the NSW Get Healthy
Information and Coaching Service (GHS) [19, 20].
Consultation
The consultation will involve a low back pain clinical as-
sessment and detailed low back pain education based on
principles recommended by clinical practice guidelines.
The consultation will also apply behaviour change tech-
niques to support a healthy lifestyle and weight manage-
ment for low back pain. This intervention content was
informed by Self Determination Theory (SDT) [21, 22].
According to SDT autonomous behaviour rather than be-
haviour controlled by rewards, punishments or self-
imposed pressures is more likely to result in long lasting
behaviour change [22]. The constructs deemed integral in
SDT to develop autonomous motivation include increas-
ing 1) perceived competence (increase interest, enjoyment
and importance) and 2) self-regulation (increase ability to
direct behaviour to act in your long term best interest and
in line with your values) [22]. The specific techniques used
in the consultation to address these key constructs in-
clude: i) provision of education and reassurance to correct
inappropriate pain beliefs and improve self-efficacy for
self-management (i.e. provide information about the about
the nature of the condition, that persistent low back pain
is multifactorial with multiple influences and not usually
the result of pathological damage), ii) acknowledging the
consequences of unhealthy lifestyle factors (overweight,
inactivity, poor diet, alcohol misuse, smoking, poor sleep)
on low back pain, iii) provide general encouragement and
examples of how improving lifestyle factors can influence
pain outcomes and quality of life, iv) prompt commitment
from the participant, v) acknowledge that monitoring of
behaviours will be conducted throughout the program, vi)
setting graded tasks to adopt better physical functioning
and healthy behaviour (e.g. begin walking 30 min daily),
vii) encourage self-monitoring of goals, viii) present the
NSW GHS as a way to support ongoing behaviour change
to improve low back pain and general health, ix) acknow-
ledge general barriers that may reduce motivation to
change lifestyle and adherence to the program (e.g. ac-
knowledge fluctuating nature of condition and that high
levels of pain are the result of a complex interaction of
factors not just the result of increased activity, and dis-
courage use of pain as a guide for progression of activity).
Lifestyle behavioural intervention - The NSW Get Healthy
Service
Following the consultation, patients randomised to the
intervention group will be referred to the established
GHS [19]. The referral to the GHS will be provided to
the service on the participants’ behalf. The GHS is a free
telephone-based government funded service to support
individuals to modify their eating behaviours, increase
their physical activity, reduce alcohol consumption and
maintain a healthy weight or reduce their weight. The
service was developed in response to evidence support-
ing the efficacy of telephone-based behaviour modifica-
tion interventions and facilitates the translation of this
evidence into a population wide approach [19]. A pre-
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post study assessing the effectiveness of the GHS in the
general population reported significant reductions in
weight, BMI, and waist circumference, and significant
improvements in physical activity and nutrition-related
behaviours [19].
The GHS service involves 10 individually tailored coach-
ing calls delivered over a 6 month period by a qualified
health professional including dieticians, exercise physiolo-
gists and psychologists [19]. The support provided is
based on national guidelines including the Australian
Guide to Healthy Eating and National Physical Activity
Guidelines [19, 23], utilises motivational interviewing
principles [19, 24], addresses health-related psychological
blocks with Socratic questioning [25], and applies self-
regulation principles including goal setting, overcoming
barriers and creating sustainable changes [19]. The pro-
gram is individually tailored to each patient with content
targeted to address individual patient goals throughout
the 6 months and phone calls scheduled according to the
patient’s preferences. These aspects are determined by the
patient and health coach together, however calls are gener-
ally provided on a tapered schedule, with a higher inten-
sity of calls (n = 6) made within the first three months of
the program [19]. This schedule facilitates initiation of
behaviour change in the first three months and mainten-
ance and prevention of relapse in the second half of the
program. In addition to the health coaching calls, partici-
pants receive an information booklet that provides add-
itional information to support them during the program
to achieve their goals, a coaching journal to record goals
and actions, and access to online services to help track
their progress. Medical clearance from a general practi-
tioner will be obtained when required, as per existing
service protocols [19].
All health coaches, regardless of multidisciplinary back-
ground, receive training to ensure they meet the require-
ments of the service and to promote consistency across
the program. The service conducts audits of coaching
quality as part of its quality improvement practices. To en-
sure the GHS health coaching is relevant for low back pain
participants, health coaches will be provided additional
training by a study investigator (CW) in evidence-based
management for low back pain (2 h interactive training
session) and provided with information resources to guide
specific advice to be provided to study participants. The
training session includes the topics of diagnosis, prognosis
and evidence-based management strategies including the
role of a healthy lifestyle and weight loss. The information
provided is contained within international clinical prac-
tice guidelines for low back pain. Resources also detail
guideline recommended advice about the nature of the
condition, the diagnosis, prognosis and evidence-based
treatments, as well as common misconceptions about
back pain and its management.
Control group
Participants randomised to the control group will con-
tinue on the usual care pathway and take part in data col-
lection during the 6 month intervention period. Currently
no active management of low back pain patients waiting
for an outpatient orthopaedic consultation occurs. Control
group patients will be informed that a face-to-face ap-
pointment to determine the need for further care will be
available in 6 months.
Data collection
Participants will be followed for 6 months (26 weeks) and
be asked to complete three self-reported questionnaires at
baseline (pre-randomisation), week 6 and 26 weeks post
randomisation to collect primary and secondary outcome
data. All participants will be mailed a questionnaire one
week prior to the 6 and 26 week time point and then
asked to provide responses in one of two ways: via tele-
phone or returned postal questionnaire. The baseline
questionnaire will be completed via telephone only. Partic-
ipants will also be asked to record the primary outcome
‘pain intensity’ at week 2, 10, 14, 18 and 22. Participants
will be asked to provide these data via telephone or reply
to text message, whichever their preference. During the
26 week telephone survey participants will be asked to at-
tend a follow up clinic appointment (intervention group)




The following demographic items will be collected at
baseline: age, Aboriginal and/or Torres Strait Islander sta-
tus, employment status, country of origin, highest level of
education, health insurance status and medical conditions.
Length of time waiting for consultation (days) and triage
classification will be obtained from hospital records.
Primary outcome
Pain intensity Pain intensity will be measured using a
0–10 NRS, as the average pain over the last week where
zero indicates ‘no pain’ and ten indicates the ‘worst pos-
sible pain’ [26]. Pain intensity will be collected at base-
line, at 2, 6, 10, 14, 18, 22 and 26 weeks post
randomisation (see Table 1). The NRS is a valid and reli-
able measure of pain intensity in adults with low back
pain [27].
Secondary outcomes
The secondary outcomes include: low back pain disability,
using the Roland Morris Disability Questionnaire (RMDQ)
[28]; self-reported weight (kg); objective weight (kg) mea-
sured to the nearest 0.1 kg by a trained assessor using
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International Society for the Advancement of Kinanthropo-
metry (ISAK) procedures [29]; BMI calculated as weight
/height squared (kg/m2); waist circumference measured at
26 weeks post randomisation taken at the level of the nar-
rowest point between the inferior rib border and the iliac
crest by trained assessors using a flexible tape measure to
the nearest 0.1 cm [29]; quality of life assessed using the 12-
item Short Form Health Survey version 2 (SF-12.v2) [30];
global perceived change in condition measured using the
Global Perceived Effect Scale (−5 to 5 scale) [29]; psycho-
logical distress using the Depression, Anxiety and Stress
Scale-21 (DASS-21) [31]; sleep quality measured using item
6 of the Pittsburgh Sleep Quality Index [32]; health behav-
iours including physical activity reported as the frequency
and total minutes of spent participating in physical activity
measured by the Active Australia Survey [33], dietary in-
take measured by a short food frequency questionnaire
(FFQ) [34], alcohol consumption measured using the
Alcohol Use Disorders Identification Test (AUDIT)
[35] and self-reported current smoking status [36];
health care utilisation including medication use, type of
health services utilised for low back pain and the
number of sessions [37]; and attitudes and beliefs mea-
sured by the Survey of Pain Attitudes (SOPA) [38] and
the Fear Avoidance Beliefs Questionnaire (FABQ)
[39]. See Table 1 for data collection time points for sec-
ondary outcomes.
Intervention and data integrity
The delivery of the intervention will be assessed using at-
tendance records for the physiotherapy consultation and
data regarding delivery of the GHS intervention including,
commencement and number, length, timing of coaching
calls and achievement of identified goals which will be pro-
vided by the GHS. Patient reported receipt of care (as well
as additional care) will be collected at all secondary collec-
tion time points. Participants will be monitored for adverse
events throughout the intervention period. All adverse
events will be recorded and serious adverse events will be
assessed and managed on a case-by-case basis according to
Good Clinical Practice (GCP) guidelines [40]. Trial data in-
tegrity will be monitored by regularly scrutinising data files
for omissions and errors. Manually entered data (i.e. data
not recorded directly by participant) will be double entered
Table 1 Trial Measures
Outcome Domain Measures Time point (weeks)
Primary Pain intensity Pain intensity over the previous week as measured by the 0–10
Numerical Rating Scale (NRS) [26]
0, 2, 6, 10, 14, 18, 22, 26
Secondary Disability Roland Morris Disability Questionnaire (RMDQ) [28] 0, 6, 26
Self-reported weight Self-reported weight (kg) 0, 6, 26
Objective weight Measured to the nearest 0.1 kg [29] 0a, 26
BMI Calculated as weight/height squared (kg/m2) 0a, 26
Waist circumference Measured to the nearest 0.1 cm [29] 26
Quality of life Short Form 12 version 2 (SF12.v2) [30] 0, 6, 26
Perceived change in condition Global Perceived Effect Scale [43] 6, 26
Psychological distress Depression, Anxiety and Stress Scale-21 (DASS-21) [31] 0, 26
Sleep quality Item 6 of the Pittsburgh sleep quality index [32] 0, 6, 26
Health behaviours Physical Activity measured using the Active Australia Survey [33] 0, 6, 26
Dietary intake measured using a short food frequency questionnaire [34] 0, 6, 26
Alcohol Consumption measured using the alcohol use disorders
identification test (AUDIT) [35]
0, 6, 26
Self-reported smoking status [36] 0, 6, 26
Health care utilisation Medication use for low back pain 0, 6, 26
Visits for low back pain – type and number of sessions 0, 6, 26
Attended orthopaedic consultation, received surgery 26
Pain attitudes Survey of Pain Attitudes (SOPA) [38] 0, 6, 26
Fear Avoidance Fear Avoidance Beliefs Questionnaire (FABQ) [39] 0, 26
Economic Quality of life (SF12.v2) 0, 6, 26
Health care utilisation (including estimated out of pocket cost)
Absenteeism (days off normal work due to lower back pain in the
past 6 weeks)
GHS: Get Healthy Information and Coaching Service; aIntervention group only
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and the source of any inconsistencies will be explored and
resolved in consultation with the lead investigator (CW).
Data will be stored on password protected files, with access
given to approved researchers only.
Sample size
Sample size was calculated using Stata sample size calculator.
Using a standard deviation of 2.3, a two-sided alpha of 0.025
(to account for multiple outcomes of interest – pain and
weight) [41] and allowing for 15 % loss to follow up, a sam-
ple of 80 participants per group will provide 90 % power to
detect a clinically meaningful difference of 1.5 in pain inten-
sity (pain numerical rating scale) between intervention and
control groups at 26 weeks post randomisation. This sample
also provides power 80 % to detect a 6 % reduction in weight
in the underlying sampling population and based on evi-
dence from other musculoskeletal conditions is hypothesized
to lead to a clinically meaningful reduction in pain [42].
Statistical analysis
Primary outcomes analysis
Between group differences in pain intensity will be assessed
using linear mixed models, with random intercepts for indi-
viduals to account for correlation of repeated measures. We
will obtain estimates of the effect of the intervention and
95 % confidence intervals by constructing linear contrasts to
compare the adjusted mean change in outcome from base-
line to each time point between the treatment and control
groups. Dummy coded variables representing group allo-
cation will be used to ensure blinding of the analyses.
Missing data will be assessed for randomness if this is
more than 10 %.
Secondary outcomes analysis
Linear mixed models will be used to assess treatment ef-
fects on secondary outcomes as per the primary outcome.
We will compare the adjusted mean change (continuous
variables) or difference in proportions (dichotomous vari-
ables) in outcome from baseline to each time point be-
tween the treatment and control groups.
An economic evaluation will also be undertaken. We
will develop costing models from the perspective of the
health service and broader societal perspective. These
models will utilize data regarding patient quality of life
(SF12v2), health care and community services use, work
absenteeism. We will calculate costs based on published
normative data and estimated out of pocket costs reported
by participants. We will also investigate the mechanisms
underlying the intervention using causal mediation ana-
lysis and include the following measures at baseline,
6 weeks and 6 months: pain attitudes (SOPA), fear avoid-
ance beliefs (FABQ) and symptoms of psychological dis-
tress (DASS 21), weight loss (kg), health behaviours
(physical activity (MVPA), diet, alcohol, smoking, sleep
quality).
Discussion
This is the first RCT designed to evaluate the effective-
ness of a lifestyle behavioural intervention for low back
pain patients who are overweight or obese. The results
will inform care pathways by providing robust evidence
about the effectiveness of such management for over-
weight patients with low back pain.
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